Zhang H - Search Results

1

Advances in clinical immunotherapy for gastric cancer.

Li K, Zhang A, Li X, Zhang H, Zhao L. Li K, et al. Among authors: zhang a, zhang h. Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188615. doi: 10.1016/j.bbcan.2021.188615. Epub 2021 Aug 14. Biochim Biophys Acta Rev Cancer. 2021. PMID: 34403771 Review.

2

Perspectives from recent advances of Helicobacter pylori vaccines research.

Zhang Y, Li X, Shan B, Zhang H, Zhao L. Zhang Y, et al. Among authors: zhang h. Helicobacter. 2022 Dec;27(6):e12926. doi: 10.1111/hel.12926. Epub 2022 Sep 22. Helicobacter. 2022. PMID: 36134470 Review.

3

Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy.

Han L, Dai S, Li Z, Zhang C, Wei S, Zhao R, Zhang H, Zhao L, Shan B. Han L, et al. Among authors: zhang c, zhang h. J Exp Clin Cancer Res. 2019 Dec 21;38(1):501. doi: 10.1186/s13046-019-1498-z. J Exp Clin Cancer Res. 2019. PMID: 31864387 Free PMC article.

4

Challenges in the clinical utility of the serum test for HER2 ECD.

Lam L, McAndrew N, Yee M, Fu T, Tchou JC, Zhang H. Lam L, et al. Among authors: zhang h. Biochim Biophys Acta. 2012 Aug;1826(1):199-208. doi: 10.1016/j.bbcan.2012.03.012. Epub 2012 Apr 3. Biochim Biophys Acta. 2012. PMID: 22521738 Free PMC article. Review.

5

Progress of molecular targeted therapies for prostate cancers.

Fu W, Madan E, Yee M, Zhang H. Fu W, et al. Among authors: zhang h. Biochim Biophys Acta. 2012 Apr;1825(2):140-52. doi: 10.1016/j.bbcan.2011.11.003. Epub 2011 Nov 29. Biochim Biophys Acta. 2012. PMID: 22146293 Free PMC article. Review.

6

Targeting erbB receptors.

Cai Z, Zhang H, Liu J, Berezov A, Murali R, Wang Q, Greene MI. Cai Z, et al. Among authors: zhang h. Semin Cell Dev Biol. 2010 Dec;21(9):961-6. doi: 10.1016/j.semcdb.2010.09.005. Epub 2010 Sep 17. Semin Cell Dev Biol. 2010. PMID: 20850557 Free PMC article. Review.

7

Receptor-targeted cancer therapy.

Richter M, Zhang H. Richter M, et al. Among authors: zhang h. DNA Cell Biol. 2005 May;24(5):271-82. doi: 10.1089/dna.2005.24.271. DNA Cell Biol. 2005. PMID: 15869404 Review.

8

ErbB receptors: from oncogenes to targeted cancer therapies.

Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI. Zhang H, et al. Among authors: zhang g. J Clin Invest. 2007 Aug;117(8):2051-8. doi: 10.1172/JCI32278. J Clin Invest. 2007. PMID: 17671639 Free PMC article. Review.

9

Mesothelin, a novel immunotherapy target for triple negative breast cancer.

Tchou J, Wang LC, Selven B, Zhang H, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Tchou J, et al. Among authors: zhang pj, zhang h. Breast Cancer Res Treat. 2012 Jun;133(2):799-804. doi: 10.1007/s10549-012-2018-4. Epub 2012 Mar 15. Breast Cancer Res Treat. 2012. PMID: 22418702 Free PMC article.

10

A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γ.

Zhang H, Lam L, Nagai Y, Zhu Z, Chen X, Ji MQ, Greene MI. Zhang H, et al. Oncoimmunology. 2018 Feb 8;7(4):e1300739. doi: 10.1080/2162402X.2017.1300739. eCollection 2018. Oncoimmunology. 2018. PMID: 29632709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119,758 results

Search Page